Humacyte Announces Publication of Preclinical Data on Use of the CTEV as a Coronary Artery Bypass Graft (CABG)

- Results were published in JACC: Basic to Translational Science -

- Publication evaluated coronary tissue engineered vessel (CTEV) as a conduit for CABG in a nonhuman primate model -

Read more at globenewswire.com